Package 0135-0400-01

{"route": ["TOPICAL"], "spl_id": "1b52dd69-d74d-3137-e063-6394a90ab541", "openfda": {"nui": ["N0000185370", "N0000175629", "N0000184306", "N0000185001", "M0000728", "M0009417"], "unii": ["PDC6A3C0OX", "V13007Z41A"], "rxcui": ["2637870", "2637875"], "spl_set_id": ["65bd242f-4c6a-436c-8ec0-7b2e0d73ed9d"], "pharm_class_cs": ["Allergens [CS]", "Glycerol [CS]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]", "Increased IgG Production [PE]"], "pharm_class_epc": ["Non-Standardized Chemical Allergen [EPC]"], "manufacturer_name": ["Haleon US Holdings LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 PACKAGE (0135-0400-01)  / 3 g in 1 TUBE", "package_ndc": "0135-0400-01", "marketing_start_date": "20230601"}], "brand_name": "ABREVA Rapid Pain Relief", "product_id": "0135-0400_1b52dd69-d74d-3137-e063-6394a90ab541", "dosage_form": "GEL", "pharm_class": ["Allergens [CS]", "Amide Local Anesthetic [EPC]", "Amides [CS]", "Antiarrhythmic [EPC]", "Cell-mediated Immunity [PE]", "Glycerol [CS]", "Increased Histamine Release [PE]", "Increased IgG Production [PE]", "Local Anesthesia [PE]", "Non-Standardized Chemical Allergen [EPC]"], "product_ndc": "0135-0400", "generic_name": "glycerin, lidocaine", "labeler_name": "Haleon US Holdings LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "ABREVA", "brand_name_suffix": "Rapid Pain Relief", "active_ingredients": [{"name": "GLYCERIN", "strength": "200 mg/g"}, {"name": "LIDOCAINE HYDROCHLORIDE", "strength": "40 mg/g"}], "application_number": "M017", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20230601", "listing_expiration_date": "20261231"}